These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4578564

  • 1. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR, Redmon LW, Pearson JW.
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract] [Full Text] [Related]

  • 2. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR, Redmon LW, Bass LR.
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract] [Full Text] [Related]

  • 3. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A, McCoy JL, Perk K, Glynn JP.
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract] [Full Text] [Related]

  • 4. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW, Chaparas SD, Chirigos MA.
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract] [Full Text] [Related]

  • 5. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J, Moloney JB, Groupé V.
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract] [Full Text] [Related]

  • 6. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
    Chirigos MA, Pearson JW, Pryor J.
    Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224
    [No Abstract] [Full Text] [Related]

  • 7. Immunization with p30 enhances the growth of a rat Moloney sarcoma.
    Jones JM, Kennel SJ, Feldman JD.
    J Immunol; 1977 Jan; 118(1):371-3. PubMed ID: 830759
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW.
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A.
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract] [Full Text] [Related]

  • 10. Induction and regression of primary moloney sarcoma virus-induced tumors in mice.
    Fefer A, McCoy JL, Glynn JP.
    Cancer Res; 1967 Sep; 27(9):1626-31. PubMed ID: 4860892
    [No Abstract] [Full Text] [Related]

  • 11. Antigenicity of a virus-induced murine sarcoma (Moloney).
    Fefer A, McCoy JL, Glynn JP.
    Cancer Res; 1967 May; 27(5):962-7. PubMed ID: 4290556
    [No Abstract] [Full Text] [Related]

  • 12. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 13. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
    Pazmiño NH, Yuhas JM.
    Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
    [No Abstract] [Full Text] [Related]

  • 14. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
    Sjögren HO.
    Ann Med Exp Biol Fenn; 1966 Nov; 44(2):227-31. PubMed ID: 4290659
    [No Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies to the envelope proteins of Moloney leukemia virus: characterization of recombinant viruses.
    Cicurel L, Lee JC, Enjuanes L, Ihle JN.
    Transplant Proc; 1980 Sep; 12(3):394-7. PubMed ID: 7222218
    [No Abstract] [Full Text] [Related]

  • 16. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F, Kao KJ, Pizzo SV, Collins JJ.
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract] [Full Text] [Related]

  • 17. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA, Chirigos MA, Chan SP.
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of xenogeneic antiserum on the growth of Moloney virus-induced sarcomas.
    Pierce GE.
    J Surg Oncol; 1977 May; 9(3):249-56. PubMed ID: 875394
    [Abstract] [Full Text] [Related]

  • 19. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH, Herberman RB, Nunn M, Soares N.
    J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M, Pearson G, Pettigrew H, Redmon L, Orr T.
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.